Jump to content
Afrii Diaspora Dialogue
  • Medicinal cannabis growers eyeing Germany need to EU meet standards

    Medicinal cannabis growers eyeing Germany need to EU meet standards

    The continued development of the cannabis industry in South Africa has medicinal cannabis growers looking at Europe as a lucrative export opportunity.

    Regulations currently limit the cultivation and economic growth of cannabis in South Africa

    Due to the state of its market, Germany is currently being looked at as having the greatest market potential. Growers in South Africa first need to obtain a Good Manufacturing Practice (GMP) stamp of approval before they can hope to export their product into the EU.

    The process of large-scale cultivation is a difficult and expensive process due to growers requiring a permit from the South African Health Products Regulatory Authority (Sahpra). The permit is also not easily obtained as only a select number of people obtain one among the hundreds of applications received.

    “The process to obtain a licence from Sahpra to cultivate cannabis for medical research purposes is a rigorous one. There needs to be standardisation of the cannabis cultivars and assurance that crops can be grown in conditions of strict security,”

    says Sahpra.

    While steps are being taken to ease the process of obtaining a permit and ultimately increase the economical opportunity of the industry, the current market for cultivators in South Africa remains poor when focusing on the country alone. Market opportunities greatly increase when cultivators look at exporting into Europe.

    Germany currently leads the industry in Europe 

    With Germany leading the innovation of medicinal Cannabis in Europe, South African Cultivators are viewing the country as an extremely promising export avenue. Germany’s free-market approach along with roughly 200 000 patients of the medicinal plant makes it ideal for South African exports, reports Business Insider.

    GMP stamp of approval

    Those looking at entering the EU market will first need to obtain the EU’s GMP’s approval. Evaluated and controlled by the European Medicines Agency, the GMP confirms the product’s quality and compliance with specific standards. It also ensures that the product is suitable for its intended use.  

    While Germany is currently seen as the ideal location for exportation there remain a number of other underdeveloped and less competitive markets in Europe including France, Poland and Italy.

    ALSO READ: Gauteng government plans to use old mining land for cannabis

    View the full article



    User Feedback

    Recommended Comments

    There are no comments to display.

    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


Afrii-Diaspora Dialogue

A Platform for Dialogue for the African diaspora

A cultural and community website with a GO.A.L. to UpLift™ and EmPower™ the many different peoples, cultures, and communities of the Black and African diasporas.

Main links

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. Guidelines, Privacy Policy, Terms of Use